1. Home
  2. GKOS vs COLB Comparison

GKOS vs COLB Comparison

Compare GKOS & COLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$173.00

Market Cap

9.7B

Sector

Health Care

ML Signal

HOLD

Logo Columbia Banking System Inc.

COLB

Columbia Banking System Inc.

SELL

Current Price

$28.29

Market Cap

9.2B

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
GKOS
COLB
Founded
1998
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
9.7B
9.2B
IPO Year
2015
1996

Fundamental Metrics

Financial Performance
Metric
GKOS
COLB
Price
$173.00
$28.29
Analyst Decision
Strong Buy
Buy
Analyst Count
14
14
Target Price
★ $198.69
$33.79
AVG Volume (30 Days)
723.3K
★ 2.5M
Earning Date
10-28-2026
10-22-2026
Dividend Yield
N/A
★ 5.12%
EPS Growth
N/A
★ N/A
EPS
N/A
★ 1.38
Revenue
★ $507,442,000.00
$177,000,000.00
Revenue This Year
$36.18
$19.03
Revenue Next Year
$23.04
$2.24
P/E Ratio
★ N/A
$20.95
Revenue Growth
★ 32.33
18.94
52 Week Low
$73.16
$23.83
52 Week High
$191.62
$33.68

Technical Indicators

Market Signals
Indicator
GKOS
COLB
Relative Strength Index (RSI) 56.54 33.14
Support Level $148.39 $27.79
Resistance Level $184.68 $30.06
Average True Range (ATR) 6.50 0.60
MACD 1.09 -0.05
Stochastic Oscillator 89.32 10.97

Price Performance

Historical Comparison
GKOS
COLB

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About COLB Columbia Banking System Inc.

Columbia Banking System Inc is a registered bank holding company whose wholly-owned banking subsidiary is Columbia State Bank. The company provides a full range of banking services to small and medium sized businesses, professionals, and individuals throughout Washington, Oregon, Idaho, and California. The company's subsidiary Columbia Trust Company is an Oregon trust company that provides agency, fiduciary, and other related trust services with offices in Washington, Oregon, and Idaho. The firm offers various products and services under Personal Banking, Business Banking, and Wealth Management divisions.

Share on Social Networks: